EPA/DHA (fish oil)
from Peter Attia protocol
2g EPA + 1.5g DHA/day (with meals)
cardiovascularlongevity
Rationale
cardiovascular, anti-inflammatory
Evidence
limited
Evidence details are expanded on protocol and compound pages.
supps.info - what they actually take
* not medical advice. do your own research. we use affiliate links. last updated 2025-04. sources linked per person.
4 people - 31/31 supplements shown
filter:
Peter AttiaMD - longevity-focused physician
source7 shown
buy ->
Rationale
sleep quality, cognitive
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
general Mg sufficiency
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
target 60-80 ng/mL
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
methylation support
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
ASCVD risk reduction
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
nutritional insurance
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Andrew HubermanPhD - Stanford neuroscience
source10 shown
Rationale
sleep onset and depth
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
sleep (skip if vivid dreams)
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
sleep onset
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
free testosterone support
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
luteinizing hormone
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Omega-3 (fish oil)
from Andrew Huberman protocol
2g EPA/day min (with meals)
cardiovascularcognitive
Rationale
mood, inflammation
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
cognitive + muscle
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
cortisol modulation, fatigue
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
focus, power output
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
foundational nutrition
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Bryan JohnsonTech founder - Blueprint protocol
source8 shown
Rationale
mTOR inhibition / longevity
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
glucose regulation, longevity
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
neuroprotection
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
inflammation
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
bone + vascular health
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
NAD+ precursor
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
cognitive + physical
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
vascular function
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rhonda PatrickPhD - biomedical science
source6 shown
Rationale
NRF2 pathway activation
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
immune, gene expression
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
target omega-3 index >8%
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
general sufficiency
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
calcium metabolism
Evidence
limited
Evidence details are expanded on protocol and compound pages.
Rationale
macular / eye health
Evidence
limited
Evidence details are expanded on protocol and compound pages.